HERTFORDSHIRE, England and
PITTSBURGH, May 26, 2016 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) a leading global pharmaceutical company, today
announced that the Company will present at the Goldman Sachs
37th Annual Global Healthcare Conference on Tuesday, June 7, 2016, in Rancho Palos Verdes, CA. The presentation is
scheduled to begin at 2:40 p.m. PT /
5:40 p.m. ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's website at
http://mylan.com/investors.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 1,400 generic and branded pharmaceuticals,
including antiretroviral therapies on which approximately 50% of
people being treated for HIV/AIDS in the developing world depend.
We market our products in approximately 165 countries and
territories. Our global R&D and manufacturing platform includes
more than 50 facilities, and we are one of the world's largest
producers of active pharmaceutical ingredients. Every member of our
nearly 35,000-strong workforce is dedicated to creating better
health for a better world, one person at a time. Learn more at
mylan.com.
Logo - http://photos.prnewswire.com/prnh/20140423/77793
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-goldman-sachs-37th-annual-global-healthcare-conference-300275589.html
SOURCE Mylan N.V.